|
Age (years) (range)
|
74.6 ± 5.7 (66-98 years)
|
79.2 ± 7.1 (66-101 years)
|
< 0.0001
|
|
Gender (Males)
|
49.8%
|
47.1%
|
0.085
|
|
Risk Factors/Comorbidities
| | | |
|
Hypertension
|
58.8%
|
58.2%
|
0.705
|
|
Smoking
| | |
< 0.0001
|
|
Never
|
48.9%
|
57.9%
| |
|
Current
|
18.00%
|
13.5%
| |
|
Past
|
33.1%
|
28.6%
| |
|
Family history of CVD
|
15.3%
|
8.4%
|
< 0.0001
|
|
Diabetes
|
26.2%
|
29.0%
|
0.047
|
|
History of CHF
|
8.5%
|
17.6%
|
< 0.0001
|
|
History of MI
|
25.8%
|
30.9%
|
0.0004
|
|
History of Stroke
|
6.4%
|
11.5%
|
< 0.0001
|
|
History of TIA
|
4.5%
|
7.5%
|
< 0.0001
|
|
Number of distinct prescription medications in 6 months pre-hospitalization
|
5.7 ± 4.2
|
6.6 ± 4.6
|
< 0.0001
|
|
Area in Province Patient Resides
| | |
0.035
|
|
North
|
18.1%
|
17.6%
| |
|
Central
|
35.1%
|
32.5%
| |
|
East
|
21.7%
|
20.8%
| |
|
West
|
25.0%
|
29.0%
| |
|
Factors During Index Hospitalization
|
|
Discharge Diagnosis
| | | |
|
Unstable Angina
|
46.0%
|
51.0%
|
0.001
|
|
Myocardial Infarction
|
54.0 %
|
49.0%
| |
|
In-hospital procedures
| | | |
|
CABG
|
6.0%
|
3.7%
|
0.0004
|
|
Cardiac catheterization
|
27.1%
|
15.6%
|
< 0.0001
|
|
PTCA
|
10.8%
|
5.7%
|
< 0.0001
|
|
EST
|
48.8%
|
25.1%
|
< 0.0001
|
|
Concomitant medications written at hospital discharge
| | | |
|
ASA
|
85.2%
|
75.3%
|
< 0.0001
|
|
ACE inhibitor
|
46.2%
|
47.6%
|
0.375
|
|
Beta-blocker
|
83.1%
|
75.9%
|
< 0.0001
|
|
Calcium channel blocker
|
37.4%
|
37.5%
|
0.950
|
|
Fibrates
|
6.1%
|
4.9%
|
0.0092
|
|
Cholesterol Levels measured in Hospital (Y/N)
| | | |
|
Total cholesterol
|
68.1%
|
46.0%
|
< 0.0001
|
|
LDL cholesterol
|
63.1%
|
42.0%
|
< 0.0001
|
|
HDL cholesterol
|
50.9%
|
49.1%
|
< 0.0001
|
|
Triglycerides
|
54.5%
|
45.5%
|
< 0.0001
|
|
Factors Post-Index Hospitalization
|
|
Follow-up (# years)
|
2.7 ± 1.1
|
2.1 ± 1.2
|
< 0.0001
|
|
Crude Mortality
|
11.4%
|
35.9%
|
< 0.0001
|
